Publicacións en colaboración con investigadores/as de London School of Hygiene & Tropical Medicine (14)

2022

  1. Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved

    Nature Medicine, Vol. 28, Núm. 12, pp. 2512-2520

  2. Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial

    The Lancet Diabetes and Endocrinology, Vol. 10, Núm. 1, pp. 35-45

  3. Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT)

    European heart journal. Cardiovascular pharmacotherapy, Vol. 8, Núm. 3, pp. 291-301

2021

  1. Empagliflozin in heart failure with a preserved ejection fraction

    New England Journal of Medicine, Vol. 385, Núm. 16, pp. 1451-1461

  2. MEESSI-AHF risk score performance to predict multiple post-index event and post-discharge short-term outcomes

    European Heart Journal: Acute Cardiovascular Care, Vol. 10, Núm. 2, pp. 142-152

  3. Synergistic Impact of Systolic Blood Pressure and Perfusion Status on Mortality in Acute Heart Failure

    Circulation. Heart failure, Vol. 14, Núm. 3, pp. e007347

2020

  1. Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trial

    European Journal of Heart Failure, Vol. 22, Núm. 12, pp. 2383-2392

  2. Second-Generation Drug-Eluting Stents in Diabetes (SUGAR) trial: Rationale and study design

    American Heart Journal, Vol. 222, pp. 174-182

2019

  1. Clinical Impact of the Polypill for Cardiovascular Prevention in Latin America: A Consensus Statement of the Inter-American Society of Cardiology

    Global Heart, Vol. 14, Núm. 1, pp. 3-16.e1

2017

  1. 2-Year Outcomes of High Bleeding Risk Patients After Polymer-Free Drug-Coated Stents

    Journal of the American College of Cardiology, Vol. 69, Núm. 2, pp. 162-171

  2. Home blood pressure management intervention in low- To middle-income countries: Protocol for a mixed methods study

    JMIR Research Protocols, Vol. 6, Núm. 10

2015

  1. Polymer-free drug-coated coronary stents in patients at high bleeding risk

    New England Journal of Medicine, Vol. 373, Núm. 21, pp. 2038-2047

2014

  1. Long-term benefit of early pre-reperfusion metoprolol administration in patients with acute myocardial infarction: Results from the Metocard-CNIC trial (Effect of Metoprolol in Cardioprotection during an Acute Myocardial Infarction)

    Journal of the American College of Cardiology, Vol. 63, Núm. 22, pp. 2356-2362

2013

  1. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: The effect of Metoprolol in Cardioprotection during an Acute Myocardial Infarction (METOCARD-CNIC) Trial

    Circulation, Vol. 128, Núm. 14, pp. 1495-1503